Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Apr 2023 - Mar 2024
Lobbyists (Full time equivalent)
2 Fte (2)
Lobbyists with EP accreditation
2
High-level Commission meetings
6
Lobbying Costs over the years
-
Info
The European Association of Hospital Pharmacists (EAHP)
EU Transparency Register
82950919755-02 First registered on 18 Oct 2012
Goals / Remit
EAHP is an association of 36 national hospital pharmacy associations. Its mission is to represent and develop the hospital pharmacy profession within Europe to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals
In the interest of patients and public health, EAHP seeks to
- to promote and further develop hospital pharmacy and to obtain and maintain general joint pharmaceutical principles and a joint pharmaceutical policy;
- to foster research and education activities;
- to promote co-operation with other organisations in the domain of public health;
- to promote the position and function of hospital pharmacists;
- to support and uphold the interests of hospital pharmacists
Detailed information on the goals of EAHP can be found under https://eahp.eu/about-us/who-we-are/Main EU files targeted
The main EU initiatives, policies and legislative files currently followed by EAHP include developments in:
- Shortages (including Critical Medicines Alliance, Union list of critical Medicines, MSSG, etc.)
-Procurement of Medicines and Medical Devices
-Revision of the pharmaceutical legislation
-Healthcare Workforce shortage and creation of a talent pool
-Recognition of professional qualification and specialisations
- Access to medicines
-Health Technology Assessment
-ATMPs
-Orphan Medicinal Products
-Europe's beating cancer plan
- Clinical trial regulation
- Medical devices regulation
- EU initiatives in the area of health systems
- tackling antimicrobial resistance, including the better use of antibiotics and an improved research environment for new antibiotics and promotion of a One health Approach
- Digital health (including ePI, EDHS and AI Act)
- Patient safety
- The implementation of the Falsified Medicines DirectiveAddress
Head Office
Boulevard Brand Whitlock 87, Box 11 (4th floor)
Brussels 1200
BELGIUMEU Office
Boulevard Brand Whitlock 87, Box 11 (4th floor)
Brussels 1200
BELGIUMWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 100% 2 Lobbyists (Full time equivalent)
2
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date James Evans 14 May 2024 13 May 2026 Anna Maria V Mirabile 06 May 2024 05 May 2026 Stephanie KOHL 12 Aug 2023 11 Mar 2024 Mr Diogo Jose TEIXEIRA PEREIRA 13 Apr 2023 11 Mar 2024 Stephanie KOHL 21 Jun 2022 21 Jun 2023 Stephanie KOHL 11 Mar 2020 11 Mar 2021 Mr Petr HORÁK 28 Feb 2020 27 Feb 2021 Ms Hildur Kristjana ÖNNUDÓTTIR 19 Jul 2019 01 Apr 2020 Stephanie KOHL 06 Mar 2019 06 Mar 2020 Mr Petr HORÁK 26 Feb 2019 28 Feb 2020 Ms Valentina DIMULESCU 06 Nov 2018 20 Apr 2019 Mr Boris LAMBERT 20 Sep 2018 03 Oct 2018 Stephanie KOHL 03 Mar 2018 02 Mar 2019 Mr Jordi MALLARACH PARÉS 14 Dec 2017 06 Sep 2018 Stephanie KOHL 20 Mar 2017 01 Mar 2018 Mr Richard Perceval Price 10 Oct 2016 28 Apr 2017 Mr Richard Perceval-Price 03 Sep 2014 28 Aug 2015 Mr David Preece 03 Sep 2014 28 Aug 2015 Mr Roberto Frontini 08 Feb 2014 07 Aug 2014 Mr David Preece 17 May 2013 16 May 2014 Mr Richard Perceval-Price 11 Apr 2013 10 Apr 2014 Complementary Information
The two persons working 100% on the activities under heading 9 are the two policy officers, employees of the association. Other people are involved less than 10% in the policy activities. These are notably the ten unpaid and volunteers elected Board members, who participate and bring the expertise as hospital pharmacists in working groups and stakeholder networks.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade unions and professional associations
-
Networking
Affiliation
EAHP is a member of the Federation of European & International Associations established in Belgium. www.faib.org
EAHP is a member of the International Pharmaceutical Federation (FIP). www.fip.org
EAHP is a member of the European Medicines Agency's Healthcare Professional's Working Party. http://www.ema.europa.eu/
EAHP is an affiliate stakeholder in the European Medicines Verification Organisation (EMVO) https://emvo-medicines.euMember organisations
Information on the 36 national country members of EAHP is available on the EAHP website here: https://eahp.eu/about-us/members/
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Apr 2023 - Mar 2024
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
100,000€ - 199,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
Antimicrobial Resistance One Health Network#E03853#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3853 #MEMBER #C#Professionals06 - Borderline and Classification (B&C)#X03565/8#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100603 #OBSERVER #C#ProfessionalsMedical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #OBSERVER #C#Professionals09 - Unique Device Identification (UDI)#X03565/10#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=100606 #OBSERVER #C#Professionals
Groups (European Parliament)
N/A
Communication activities
-Joint communication campaign with EMA on shortages
-Communication campaign and exchanges with ECDC on AMR
-Amendments on pending legislative files.
-Position papers on key policy topics.
-Joint statements and activities with other stakeholder organisations on topics of common interest.
-EAHP international annual congress of EAHP
-Academy Seminar Programme
-Synergy Masterclass
-Access to open learning courses
-Scientific publications on the European Journal of Hospital Pharmacy (EJHP)
-EU monitor (monthly newsletter)
-Social Media Communication
-Press releases
-Participation in events of policy magazines (e.g. POLITICO)
-Attendance of the meetings of the Interregional Group on Health and Wellbeing of the Committee of the Regions
-Participation in events hosted by MEPs (e.g. on vaccination, shortages, rare diseases, etc.)
-Collection of data through surveys and following analysis, draft and publication of the report and results (e.g. shortages, workforce, etc.)
-Participation in policy events organised by other stakeholders organisations on topics of common interest.
-Project aimed at creating a common training framework for the hospital pharmacy specialisation.Other activities
None declared
- Meetings
Meetings
6 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 16 Jun 2021 Location online Subject Supply chains for medicines Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
Other Lobbyists -
Date 30 Sep 2020 Location Online Subject Call with pharmaceutical and medical device supply Chain on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 22 Sep 2020 Location Brussels Subject Exchange of views on the upcoming Pharmaceutical Strategy, shortages of medicines and the role of health workforce in the health systems Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
-
Date 22 Jul 2019 Location Brussels Subject Access to medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Arunas Vinciunas (Cabinet member)
- Vytenis Andriukaitis (Commissioner)
- Alina Timofte (Cabinet member)
Other Lobbyists -
Date 01 Jul 2019 Location Brussels Subject • The current medicines shortages situation in Europe; • Our request for an investigation into the causes of shortages; and, • The general need for better information sharing about shortages. DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 03 May 2018 Location Brussels Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
Other Lobbyists
- Meetings